Ørsted A/S (DNNGY)

Checkpoint Therapeutics Revenue

Ørsted had revenue of 17.14B DKK in the quarter ending June 30, 2025, with 14.06% growth. This brings the company's revenue in the last twelve months to 74.68B, up 2.08% year-over-year. In the year 2024, Ørsted had annual revenue of 71.03B, down -10.37%.

• Revenue (ttm): 74.68B DKK
• Revenue Growth: +2.08%
• P/S Ratio: 1.20
• Revenue / Employee: 9.02M DKK
• Employees: 8,278
• Market Cap: 14.08B USD

Revenue Chart

* This company reports financials in DKK.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	71.03B	-8.22B	-10.37%
Dec 31, 2023	79.26B	-35.16B	-30.73%
Dec 31, 2022	114.42B	36.74B	47.31%
Dec 31, 2021	77.67B	27.52B	54.88%
Dec 31, 2020	50.15B	-20.25B	-28.76%